Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Jiangsu Kanion Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥201.83 Million ≈ $29.53 Million USD) by net assets (CN¥4.91 Billion ≈ $718.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)

Cash flow conversion efficiency of Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024. This chart illustrates how Jiangsu Kanion Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jiangsu Kanion Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.

Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Jiangsu Kanion Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jiangsu Kanion Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Kanion Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Jiangsu Kanion Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Zhejiang Yankon Group Co Ltd SHG:600261	0.022x
Tansun Technology Co Ltd SHE:300872	0.019x
Dong Yi Ri Sheng Home Decoration Group Co Ltd SHE:002713	-0.017x
Metropolitan Kentjana Tbk JK:MKPI	0.034x
Corbion N.V. F:CSU	0.038x
Indian Energy Exchange Limited NSE:IEX	-0.006x
Bingo Software Co Ltd SHG:688227	-0.028x
Malaysia Building Society Bhd KLSE:1171	0.006x

Annual Cash Flow Conversion Efficiency for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024. Review Jiangsu Kanion Pharmaceutical Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.71 Billion ≈ $688.50 Million	CN¥702.49 Million ≈ $102.80 Million	0.149x	-17.38%
2023-12-31	CN¥5.38 Billion ≈ $787.34 Million	CN¥972.32 Million ≈ $142.28 Million	0.181x	-10.47%
2022-12-31	CN¥4.93 Billion ≈ $722.00 Million	CN¥995.94 Million ≈ $145.74 Million	0.202x	-0.60%
2021-12-31	CN¥4.47 Billion ≈ $654.50 Million	CN¥908.30 Million ≈ $132.91 Million	0.203x	+25.32%
2020-12-31	CN¥4.33 Billion ≈ $633.14 Million	CN¥701.10 Million ≈ $102.59 Million	0.162x	-28.45%
2019-12-31	CN¥4.09 Billion ≈ $598.12 Million	CN¥925.73 Million ≈ $135.46 Million	0.226x	+38.52%
2018-12-31	CN¥3.89 Billion ≈ $569.56 Million	CN¥636.39 Million ≈ $93.12 Million	0.164x	+53.44%
2017-12-31	CN¥3.59 Billion ≈ $525.84 Million	CN¥382.93 Million ≈ $56.03 Million	0.107x	+14.25%
2016-12-31	CN¥3.21 Billion ≈ $469.11 Million	CN¥299.02 Million ≈ $43.76 Million	0.093x	-47.99%
2015-12-31	CN¥2.87 Billion ≈ $420.08 Million	CN¥514.80 Million ≈ $75.33 Million	0.179x	+47.14%
2014-12-31	CN¥2.56 Billion ≈ $374.06 Million	CN¥311.54 Million ≈ $45.59 Million	0.122x	-39.25%
2013-12-31	CN¥1.93 Billion ≈ $283.08 Million	CN¥388.11 Million ≈ $56.79 Million	0.201x	+56.12%
2012-12-31	CN¥1.65 Billion ≈ $241.54 Million	CN¥212.11 Million ≈ $31.04 Million	0.129x	+110.14%
2011-12-31	CN¥1.47 Billion ≈ $215.81 Million	CN¥90.19 Million ≈ $13.20 Million	0.061x	-54.27%
2010-12-31	CN¥1.24 Billion ≈ $182.08 Million	CN¥166.40 Million ≈ $24.35 Million	0.134x	+759.34%
2009-12-31	CN¥1.08 Billion ≈ $157.77 Million	CN¥-21.87 Million ≈ $-3.20 Million	-0.020x	-133.16%
2008-12-31	CN¥954.72 Million ≈ $139.71 Million	CN¥58.39 Million ≈ $8.54 Million	0.061x	-63.20%
2007-12-31	CN¥557.95 Million ≈ $81.65 Million	CN¥92.73 Million ≈ $13.57 Million	0.166x	-24.83%
2006-12-31	CN¥492.91 Million ≈ $72.13 Million	CN¥108.98 Million ≈ $15.95 Million	0.221x	-0.20%
2005-12-31	CN¥457.89 Million ≈ $67.00 Million	CN¥101.44 Million ≈ $14.84 Million	0.222x	+323.09%
2004-12-31	CN¥414.10 Million ≈ $60.60 Million	CN¥21.68 Million ≈ $3.17 Million	0.052x	+14.61%
2003-12-31	CN¥374.88 Million ≈ $54.86 Million	CN¥17.13 Million ≈ $2.51 Million	0.046x	+36.56%
2002-12-31	CN¥333.38 Million ≈ $48.78 Million	CN¥11.15 Million ≈ $1.63 Million	0.033x	-88.24%
2001-12-31	CN¥73.91 Million ≈ $10.82 Million	CN¥21.02 Million ≈ $3.08 Million	0.284x	--

About Jiangsu Kanion Pharmaceutical Co Ltd

SHG:600557 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.05 Billion

CN¥7.21 Billion CNY

Market Cap Rank

#8367 Global

#1921 in China

Share Price

CN¥12.73

Change (1 day)

-0.78%

52-Week Range

CN¥10.87 - CN¥16.39

All Time High

CN¥33.10